Dwight H. Egan - Nov 23, 2025 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Signature
/s/ Dwight H. Egan
Stock symbol
CODX
Transactions as of
Nov 23, 2025
Transactions value $
-$17,351
Form type
4
Date filed
11/24/2025, 05:31 PM
Previous filing
Aug 15, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Egan Dwight H Chief Executive Officer, Director 2401 S. FOOTHILL DRIVE SUITE D, SALT LAKE CITY /s/ Dwight H. Egan 2025-11-24 0001712187

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CODX Common Stock Award $0 +163K +25.74% $0.00 798K Nov 23, 2025 Direct F1
transaction CODX Common Stock Disposed to Issuer -$17.4K -49.6K -6.21% $0.35 748K Nov 23, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CODX Restricted Stock Unit Options Exercise $0 -163K -28.36% $0.00 413K Nov 23, 2025 Common Stock 576K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in 155,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 23, 2023. Included in 275,000 restricted stock units awarded to the Reporting Person on May 15, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2023. Included in 275,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024. Included in 275,000 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2025.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.